Search Ontology:
ChEBI
beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
- Term ID
- CHEBI:148473
- Synonyms
-
- beta-D-galacto-hexopyranosyl-(1->3)-beta-D-galacto-hexopyranosyl-(1->4)-2-acetamido-2-deoxy-D-gluco-hexopyranose
- beta-D-galactopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
- Gal(b1-3)Gal(b1-4)GlcNAc
- N-[(3R,4R,5S,6R)-5-[(2S,3R,4S,5S,6R)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- A trisaccharide consisting of two β-D-galactopyranose residues and a 2-acetamido-2-deoxy-D-glucopyranose residue joined in sequence by (1→3) and (1→4) glycosidic bonds.
- References
-
- glygen:G22670XR
- glytoucan:G22670XR
- kegg.glycan:G02459
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype where environments contain beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype modified by environments containing beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype affecting beta-D-Galp-(1->3)-beta-D-Galp-(1->4)-D-GlcpNAc
Human Disease Model